Hisao Uejima

803 citations
22 papers · 549 indexed · h-index 11
Topics
Lung Cancer Treatments and Mutations (14 papers)Lung Cancer Research Studies (9 papers)Cancer therapeutics and mechanisms (6 papers)
Partner nations
Japan

In The Last Decade

Hisao Uejima

21 papers receiving 533 citations

Peers

Hisao Uejima
Comparison fields: 5 of 56
  • Pulmonary and Respiratory Medicine 374
  • Oncology 371
  • Molecular Biology 127
  • Radiology, Nuclear Medicine and Imaging 44
  • Epidemiology 35
Replace Larry Schlabach with:
Larry Schlabach United States
H. Bülzebruck Germany
Daniel P. Petro United States
S. Seeber Germany
Y. Nakanishi Japan
Tatsuji Mizukami Japan
Assunta Esposito Italy
P. Danenberg United States
Raja Mudad United States
Elaine Shum United States
Hisao Uejima relative to Larry Schlabach United States Larry Schlabach's profile →
Citations per field
00.5×11.5×
Larry Schlabach · 1×
Citations per year

Countries citing papers authored by Hisao Uejima

Since Specialization
Citations

This map shows the geographic impact of Hisao Uejima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisao Uejima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisao Uejima more than expected).

Fields of papers citing papers by Hisao Uejima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisao Uejima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisao Uejima. The network helps show where Hisao Uejima may publish in the future.

Co-authorship network of co-authors of Hisao Uejima

This figure shows the co-authorship network connecting the top 25 collaborators of Hisao Uejima. A scholar is included among the top collaborators of Hisao Uejima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisao Uejima. Hisao Uejima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 220
2 12
3 18
4
切除不能な第III期非小細胞肺癌(NSCLC)に対するマイトシン/ビンデシン/シスプラチン(MVP)対毎週のイリノテカン/カルボプラチン(PC)同時併用胸部放射線療法(TRT)の無作為第III相試験:WJTOG0105
6
5 4
6 2
7 3
8 4
9 22
10
A phase I study of irinotecan in combination with amrubicin for advanced lung cancer patients.
8
11 0
12 55
13 16
14 2
15 10
16 39
17 43
18 33
19 2
20 4

About Hisao Uejima

Hisao Uejima is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 22 papers that have together received 549 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (9 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Oncology (371 citations), Pulmonary and Respiratory Medicine (374 citations) and Otorhinolaryngology (17 citations). Hisao Uejima has collaborated with scholars based in Japan. Frequent co-authors include Kazuhiko Nakagawa, Masahiro Fukuoka, Takayasu Kurata, Miyako Satouchi, Nobuyuki Yamamoto, Koji Takeda, Toyoaki Hida, Hiroyasu Kaneda, Kenji Tamura and Hiroshi Semba. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026